• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Multicenter Study Finds No Correlation between Chronic Fatigue Syndrome and XMRV

October 5, 2012

A multicenter blinded case-control study has confirmed that chronic fatigue syndrome (CFS) is not associated with xenotropic murine leukemia virus-related virus (XMRV) or polytropic murine leukemia virus (pMLV).  These results effectively resolve debate sparked by two major studies published in 2009 and 2010, which first reported a link between CFS and these viruses.  Concerns about XMRV and potential transmission through blood transfusion subsequently prompted AABB and the FDA to recommend that CFS patients be discouraged from donating blood. However, the associations reported in these studies could not be replicated by other laboratories, and it was later shown that the findings were generated through provirus recombination in mice models. In this issue of the journal mBio, Dr. Harvey Alter at the National Institutes of Health and colleagues from six clinical research sites report results from an analysis of peripheral blood samples from 147 CFS patients, who met both 1994 Fukuda and 2003 Canadian CFS criteria, and 146 frequency-matched controls. The analysis incorporated PCR and serology-based testing of samples by the investigators originally reporting XMRV or pMLV in CFS patients, as well as by the Centers for Disease Control, which first reported failure to replicate these results. Each laboratory independently found that no case or control sample was PCR positive for XMRV or pMLV, except for spiked positive controls. There were also no differences between cases and controls in serology outcomes. Thus, the authors concluded that no link exists between CFS and either XMRV or pMLV.

References

1.  Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI. A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus. MBio 2012;3.

2.  Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, Wang R, Alter HJ. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010;107: 15874-9.

3.  Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009;326: 585-9.

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • No Increased Risk of Blood Donations from MSM after Temporary Deferrals

  • Cost-Effectiveness of Transfusions to Prevent Silent Cerebral Infarcts in Children with Sickle Cell Disease

  • Pre-Hospital Transfusion Reduces Risk of Death and Improves Coagulation Status in Trauma Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley